Introduktion

Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för George Yancopoulos. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.

Genomsnittlig handelslönsamhet

Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.

Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.

Uppdateringsfrekvens: Dagligen

Se listan över mest lönsamma insiderhandlare

Se högst rankade insiders
Företag med rapporterade insiderpositioner

SEC-anmälningarna visar att George Yancopoulos har rapporterat innehav eller affärer i följande företag:

Värdepapper Titel Senaste rapporterade innehav
US:REGN / Regeneron Pharmaceuticals, Inc. Bd. Co-Chair, President & CSO, Director 56 048
Hur man tolkar diagrammen

Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av George Yancopoulos. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.

I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.

Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.

Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.

Insiderhandelshistorik

Den här tabellen visar den fullständiga listan över insideraffärer gjorda av George Yancopoulos som avslöjats för Securities Exchange Commission (SEC).

Fildatum Transaktionsdatum Schema Ticker Värdepapper Kode 10b5-1 Aktier Återstående aktier Procentuell förandring Aktie
pris		 Transaktionsvärde Återstående
värde
2024-06-12 2024-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 37 900 56 048 208,84
2024-06-12 2024-06-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −75 799 0 −100,00
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −120 836 383 −0,01 989,14 −118 697 827 299 881
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −373 836 503 −0,04 988,36 −368 658 826 766 105
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −182 836 876 −0,02 987,38 −179 703 826 314 625
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −442 837 058 −0,05 986,40 −435 989 825 674 011
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −647 837 500 −0,08 985,62 −637 696 825 456 750
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −53 838 147 −0,01 984,02 −52 153 824 753 411
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −727 838 200 −0,09 983,88 −715 281 824 688 216
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −303 838 927 −0,04 982,29 −297 634 824 069 603
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 283 839 230 −0,27 981,52 −2 240 810 823 721 030
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 223 841 513 −0,15 980,72 −1 199 421 825 288 629
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −504 842 736 −0,06 979,87 −493 854 825 771 724
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 865 843 240 −0,57 978,44 −4 760 111 825 059 746
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −9 851 848 105 −1,15 977,42 −9 628 564 828 954 789
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −6 885 857 956 −0,80 976,56 −6 723 616 837 845 511
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −5 225 864 841 −0,60 975,60 −5 097 510 843 738 880
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 778 870 066 −0,55 974,47 −4 656 018 847 853 215
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 865 874 844 −0,21 973,43 −1 815 447 851 599 395
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −784 876 709 −0,09 972,50 −762 440 852 599 502
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −406 877 493 −0,05 971,28 −394 340 852 291 401
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −846 877 899 −0,10 970,36 −820 925 851 878 074
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 930 878 745 −0,22 969,14 −1 870 440 851 626 929
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 387 880 675 −0,38 968,43 −3 280 072 852 872 090
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 428 884 062 −0,16 967,45 −1 381 519 855 285 782
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −782 885 490 −0,09 966,29 −755 639 855 640 132
2024-05-17 2024-05-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −111 886 272 −0,01 965,69 −107 192 855 864 008
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −379 786 383 −0,05 978,18 −370 730 769 224 123
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 227 786 762 −0,16 977,38 −1 199 245 768 965 444
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 886 787 989 −0,62 976,52 −4 771 277 769 487 018
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −9 242 792 875 −1,15 975,48 −9 015 386 773 433 705
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 611 802 117 −0,94 974,51 −7 416 996 781 671 038
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 653 809 728 −0,33 973,80 −2 583 491 788 513 126
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −790 812 381 −0,10 972,22 −768 054 789 813 056
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 922 813 171 −0,60 971,56 −4 782 018 790 044 417
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 669 818 093 −0,57 970,26 −4 530 144 793 762 914
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −9 501 822 762 −1,14 969,39 −9 210 174 797 577 255
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 213 832 263 −0,38 968,44 −3 111 598 805 996 780
2024-05-17 2024-05-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −907 835 476 −0,11 967,40 −877 432 808 239 482
2024-05-01 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 848 180 000 −8,56 900,00 −15 163 200 162 000 000
2024-05-01 2024-04-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 18 148 18 148
2024-05-01 2024-04-29 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −36 296 0 −100,00
2024-02-20 2024-02-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −123 601 801 608 −13,36 953,83 −117 894 342 764 597 759
2024-02-20 2024-02-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 172 723 925 209 22,95 399,66 69 030 474 369 769 029
2024-01-04 2024-01-02 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −16 848 180 000 −8,56 900,00 −15 163 200 162 000 000
2023-12-13 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −12 841 752 486 −1,68 844,09 −10 838 960 635 165 908
2023-12-13 2023-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 25 155 765 327 3,40
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −400 196 848 −0,20 810,30 −324 120 159 505 934
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −700 197 248 −0,35 806,47 −564 529 159 074 595
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −47 197 948 −0,02 805,55 −37 861 159 457 011
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −254 197 995 −0,13 804,38 −204 313 159 263 218
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −642 198 249 −0,32 803,30 −515 719 159 253 422
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 237 198 891 −0,62 802,54 −992 742 159 617 983
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −122 200 128 −0,06 801,16 −97 742 160 334 548
2023-03-27 2023-03-23 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −254 200 250 −0,13 800,59 −203 350 160 318 148
2023-02-08 2023-02-06 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −13 189 200 504 −6,17 800,08 −10 552 255 160 419 240
2021-12-23 2021-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −203 204 0 −100,00
2021-12-23 2021-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −239 063 0 −100,00
2021-12-23 2021-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −150 182 1 019 653 −12,84 610,04 −91 617 027 622 029 116
2021-12-23 2021-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 203 204 1 169 835 21,02 270,43 54 952 458 316 358 479
2021-12-23 2021-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −159 915 966 631 −14,20 610,04 −97 554 547 589 683 575
2021-12-23 2021-12-22 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 239 063 1 126 546 26,94 179,13 42 823 355 201 798 185
2021-08-17 2021-08-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 302 887 483 −0,26 626,10 −1 441 282 555 653 106
2021-08-17 2021-08-16 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −46 925 889 785 −5,01 625,25 −29 339 856 556 338 071
2021-08-17 2021-08-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −773 936 710 −0,08 625,00 −483 125 585 443 750
2021-08-06 2021-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −50 000 937 483 −5,06 600,06 −30 003 000 562 546 049
2021-08-06 2021-06-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −211 585 0 −100,00
2021-08-06 2021-06-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 211 585 213 693 10 037,24
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −2 276 2 108 −51,92 543,13 −1 236 164 1 144 918
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 514 4 384 −70,57 542,43 −5 703 109 2 378 013
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −19 911 14 898 −57,20 541,44 −10 780 612 8 066 373
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −8 099 34 809 −18,88 540,61 −4 378 400 18 818 093
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 306 42 908 −7,15 539,66 −1 784 116 23 155 731
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 868 46 214 −9,53 538,54 −2 621 613 24 888 088
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −6 636 51 082 −11,50 537,61 −3 567 580 27 462 194
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 768 57 718 −6,13 536,37 −2 021 042 30 958 204
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 154 61 486 −6,33 535,63 −2 225 007 32 933 746
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −8 236 65 640 −11,15 534,48 −4 401 977 35 083 267
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 494 73 876 −9,21 533,66 −3 999 248 39 424 666
2021-06-23 2021-06-21 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −738 81 370 −0,90 532,89 −393 273 43 361 259
2021-06-23 2021-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Class A Stock 		G - Gift 5 383 5 383
2021-06-23 2021-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Class A Stock 		G - Gift −5 383 0 −100,00
2021-06-23 2021-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Class A Stock 		G - Gift −14 000 0 −100,00
2021-06-23 2021-04-15 4 REGN REGENERON PHARMACEUTICALS, INC.
Class A Stock 		G - Gift 14 000 14 000
2021-06-23 2021-01-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 82 108 82 108
2021-01-05 2020-12-31 4 REGN REGENERON PHARMACEUTICALS, INC.
Performance Stock Units 		A - Award 620 270 620 270
2020-12-31 2020-12-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −158 079 0 −100,00
2020-12-31 2020-12-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise −240 000 158 079 −60,29
2020-12-31 2020-12-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −86 096 822 207 −9,48 483,25 −41 605 892 397 331 533
2020-12-31 2020-12-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 158 079 908 303 21,07 52,03 8 224 850 47 259 005
2020-12-31 2020-12-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes −130 714 750 224 −14,84 483,25 −63 167 540 362 545 748
2020-12-31 2020-12-30 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise 240 000 880 938 37,45 52,03 12 487 200 45 835 204
2020-12-31 2020-07-27 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −57 465 0 −100,00
2020-03-11 2020-03-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −150 000 0 −100,00
2020-03-11 2020-03-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −96 736 150 000 −39,21
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 517 799 0,00 486,31 −3 404 251 810 832
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 693 517 806 −0,33 485,63 −822 172 251 462 128
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −345 519 499 −0,07 484,72 −167 228 251 811 555
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −355 519 844 −0,07 483,80 −171 749 251 500 527
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −100 520 199 −0,02 481,68 −48 168 250 569 454
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −60 520 299 −0,01 480,34 −28 820 249 920 422
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 651 520 359 −0,32 479,60 −791 820 249 564 176
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 469 522 010 −0,28 478,43 −702 814 249 745 244
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 735 523 479 −0,90 477,50 −2 260 962 249 961 222
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 197 528 214 −1,34 476,51 −3 429 442 251 699 253
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −4 223 535 411 −0,78 475,43 −2 007 741 254 550 452
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 060 539 634 −1,29 474,52 −3 350 111 256 067 126
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −8 024 546 694 −1,45 473,39 −3 798 481 258 799 473
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 270 554 718 −1,82 472,56 −4 853 191 262 137 538
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −5 258 564 988 −0,92 471,34 −2 478 306 266 301 444
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −5 531 570 246 −0,96 470,48 −2 602 225 268 289 338
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 250 575 777 −1,24 469,46 −3 403 585 270 304 270
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −8 542 583 027 −1,44 468,49 −4 001 842 273 142 319
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −10 023 591 569 −1,67 467,53 −4 686 053 276 576 255
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −11 916 601 592 −1,94 466,58 −5 559 767 280 690 795
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −7 068 613 508 −1,14 465,45 −3 289 801 285 557 299
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −5 099 620 576 −0,81 464,59 −2 368 944 288 313 404
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −5 463 625 675 −0,87 463,54 −2 532 319 290 025 390
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −3 317 631 138 −0,52 462,43 −1 533 880 291 857 145
2020-03-11 2020-03-10 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −1 159 634 455 −0,18 461,79 −535 215 292 984 974
2020-03-11 2020-03-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −78 376 635 614 −10,98 476,42 −37 339 894 302 819 222
2020-03-11 2020-03-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 150 000 713 990 26,60 30,63 4 594 500 21 869 514
2020-03-11 2020-03-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −50 545 563 990 −8,22 476,42 −24 080 649 268 696 116
2020-03-11 2020-03-09 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 96 736 614 535 18,68 30,63 2 963 024 18 823 207
2020-02-25 2020-02-24 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		S - Sale X −118 123 517 799 −18,58 420,17 −49 631 741 217 563 606
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −150 000 0 −100,00
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		M - Exercise X −95 295 150 000 −38,85
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −77 767 444 109 −14,90 377,16 −29 330 602 167 500 150
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 150 000 521 876 40,34 21,25 3 187 500 11 089 865
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		F - Taxes X −49 405 371 876 −11,73 377,16 −18 633 590 140 256 752
2019-12-13 2019-12-12 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		M - Exercise X 95 295 421 281 29,23 21,25 2 025 019 8 952 221
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Performance Stock Units 		A - Award 25 155 25 155
2019-12-13 2019-12-11 4 REGN REGENERON PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy) 		A - Award 81 278 81 278
2019-12-13 2019-11-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Class A Stock 		G - Gift −23 367 0 −100,00
2019-12-13 2019-11-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Class A Stock 		G - Gift 23 367 23 367
2019-12-13 2019-11-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −325 986 0 −100,00
2019-12-13 2019-11-18 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 325 986 325 986
2019-12-13 2019-11-14 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −2 366 325 989 −0,72
2019-12-13 2019-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 75 036 328 352 29,62
2019-12-13 2019-08-05 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −75 036 0 −100,00
2019-12-13 2019-06-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −500 000 253 316 −66,37
2019-12-13 2019-06-13 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 500 000 500 000
2019-12-13 2019-02-19 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift 150 722 753 316 25,01
2019-12-13 2019-02-19 4 REGN REGENERON PHARMACEUTICALS, INC.
Common Stock 		G - Gift −150 722 249 278 −37,68
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −94 048 0 −100,00
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −150 000 94 048 −61,46
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 118 993 602 594 24,61
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −118 993 0 −100,00
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −48 192 118 993 −28,83 377,31 −18 183 324 44 897 249
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 94 048 167 185 128,59 16,80 1 580 006 2 808 708
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −76 863 73 137 −51,24 377,31 −29 001 179 27 595 321
2018-12-17 2018-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 150 000 150 000 16,80 2 520 000 2 520 000
2018-12-14 2018-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 129 013 129 013
2018-12-14 2018-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 176 483 601 −0,24
2018-12-14 2018-11-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −24 643 0 −100,00
2018-12-14 2018-08-22 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −3 211 484 777 −0,66
2018-12-14 2018-08-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 847 487 988 0,17
2018-12-14 2018-08-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −847 0 −100,00
2018-12-14 2018-08-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 101 187 487 141 26,22
2018-12-14 2018-08-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −101 187 75 036 −57,42
2018-12-14 2018-07-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 299 134 385 954 344,55
2018-12-14 2018-07-24 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −299 134 24 643 −92,39
2018-12-14 2018-02-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 400 000 400 000
2018-12-14 2018-02-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −400 000 86 820 −82,17
2018-12-14 2017-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 242 150 486 820 98,97
2018-12-14 2017-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −242 150 847 −99,65
2018-12-14 2017-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 89 264 244 670 57,44
2018-12-14 2017-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −89 264 500 847 −15,13
2018-12-14 2017-08-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −176 223 155 406 −53,14
2018-12-14 2017-08-03 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 176 223 176 223
2018-12-14 2017-07-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 176 223 331 629 113,40
2018-12-14 2017-07-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −176 223 323 777 −35,24
2018-12-14 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 89 427 159 324 127,94
2018-12-14 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −89 427 500 000 −15,17
2018-12-14 2015-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 1 921 569 897 0,34
2018-12-14 2015-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 921 500 000 −0,38
2018-12-14 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 43 348 612 936 7,61
2018-12-14 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −43 348 500 000 −7,98
2018-02-08 2017-08-17 5 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		W - Other 847 423 609 0,20
2017-12-20 2017-12-18 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −257 850 422 762 −37,89 386,90 −99 762 165 163 566 618
2017-12-13 2017-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −195 438 0 −100,00
2017-12-13 2017-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −95 050 680 612 −12,25 385,08 −36 601 854 262 090 069
2017-12-13 2017-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −11 124 775 662 −1,41 385,08 −4 283 630 298 691 923
2017-12-13 2017-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 195 438 786 786 33,05 21,92 4 284 001 17 246 349
2017-12-13 2017-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 139 474 139 474
2017-02-10 2016-12-20 5 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −536 64 058 −0,83
2017-02-10 2016-12-20 5 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −536 64 594 −0,82
2017-02-10 2016-12-20 5 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −670 65 130 −1,02
2017-02-10 2016-12-20 5 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 071 65 800 −1,60
2017-02-10 2016-12-20 5 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 105 66 871 −1,63
2016-12-19 2016-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 146 815 146 815
2016-12-19 2016-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −195 079 0 −100,00
2016-12-19 2016-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −95 223 591 348 −13,87 380,09 −36 193 310 224 765 461
2016-12-19 2016-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −10 429 686 571 −1,50 380,09 −3 963 959 260 958 771
2016-12-19 2016-12-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 195 079 697 000 38,87 20,32 3 964 005 14 163 040
2016-12-19 2016-07-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −500 000 67 976 −88,03
2016-12-19 2016-07-21 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 500 000 500 000
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 146 815 146 815
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −1 921 0 −100,00
2015-12-18 2015-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 1 921 501 921 0,38 52,03 99 950 26 114 950
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 900 500 000 −0,38 555,26 −1 054 994 277 630 000
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 101 501 900 −0,22 554,58 −610 593 278 343 702
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 600 503 001 −0,32 553,32 −885 312 278 320 513
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 625 504 601 −0,71 552,54 −2 002 958 278 812 237
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −4 992 508 226 −0,97 551,43 −2 752 739 280 251 063
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −6 390 513 218 −1,23 550,47 −3 517 503 282 511 112
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −4 407 519 608 −0,84 549,57 −2 421 955 285 560 969
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 780 524 015 −0,72 548,49 −2 073 292 287 416 987
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −914 527 795 −0,17 547,45 −500 369 288 941 373
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 038 528 709 −0,57 546,36 −1 659 842 288 865 449
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −5 611 531 747 −1,04 545,51 −3 060 857 290 073 306
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −4 290 537 358 −0,79 544,52 −2 335 991 292 602 178
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −602 541 648 −0,11 543,57 −327 229 294 423 603
2015-12-04 2015-12-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 098 542 250 −0,20 542,72 −595 907 294 289 920
2015-12-04 2015-11-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −1 612 567 976 −0,28
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −400 543 348 −0,07 580,29 −232 116 315 299 411
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 500 543 748 −0,28 579,53 −869 295 315 118 278
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −268 545 248 −0,05 578,73 −155 100 315 551 375
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 996 545 516 −0,36 577,58 −1 152 850 315 079 131
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −865 547 512 −0,16 576,48 −498 655 315 629 718
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 441 548 377 −0,44 575,64 −1 405 137 315 667 736
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 693 550 818 −0,49 574,55 −1 547 263 316 472 482
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 629 553 511 −0,47 573,47 −1 507 653 317 421 953
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −5 723 556 140 −1,02 572,43 −3 276 017 318 351 220
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −7 800 561 863 −1,37 571,41 −4 456 998 321 054 137
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −6 330 569 663 −1,10 570,67 −3 612 341 325 089 584
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 223 575 993 −0,38 569,47 −1 265 932 328 010 734
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 600 578 216 −0,28 568,49 −909 584 328 710 014
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 350 579 816 −0,23 567,61 −766 274 329 109 360
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 700 581 166 −0,29 566,66 −963 322 329 323 526
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 000 582 866 −0,17 565,89 −565 890 329 838 041
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 000 583 866 −0,17 564,57 −564 570 329 633 228
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −530 584 866 −0,09 563,76 −298 793 329 724 056
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 585 396 −0,02 562,36 −56 236 329 203 295
2015-11-03 2015-11-02 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 200 585 496 −0,20 561,75 −674 100 328 902 378
2015-11-03 2015-10-30 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −182 818 0 −100,00
2015-11-03 2015-10-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −92 316 586 696 −13,60 559,08 −51 612 029 328 010 000
2015-11-03 2015-10-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −3 806 679 012 −0,56 559,08 −2 127 858 379 622 029
2015-11-03 2015-10-30 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 182 818 682 818 36,56 11,64 2 128 002 7 948 002
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 172 723 172 723
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 240 000 398 079 151,82
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −3 264 0 −100,00
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 3 264 569 588 0,58
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −3 264 500 000 −0,65
2014-12-18 2014-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 3 264 503 264 0,65 30,63 99 976 15 414 976
2014-12-18 2014-11-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −2 313 566 324 −0,41
2014-12-18 2014-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 294 568 637 0,05
2014-12-18 2014-08-28 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −294 500 000 −0,06
2014-08-29 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −5 720 0 −100,00
2014-08-29 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −310 500 294 −0,06 351,33 −108 912 175 768 291
2014-08-29 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −5 116 500 604 −1,01 351,33 −1 797 404 175 877 203
2014-08-29 2014-08-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 5 720 505 720 1,14 314,31 1 797 853 158 952 853
2014-08-29 2014-03-06 4 REGN REGENERON PHARMACEUTICALS INC
Class A Stock 		G - Gift 23 367 23 367
2014-08-29 2014-03-06 4 REGN REGENERON PHARMACEUTICALS INC
Class A Stock 		G - Gift −23 367 0 −100,00
2014-08-29 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift 568 343 568 343
2014-08-29 2014-02-13 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		G - Gift −568 343 500 000 −53,20
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 000 1 068 343 −0,09 328,50 −328 500 350 950 676
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −600 1 069 343 −0,06 327,88 −196 728 350 616 183
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −2 100 1 069 943 −0,20 326,36 −685 356 349 186 597
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 932 1 072 043 −0,18 325,44 −628 750 348 885 674
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 700 1 073 975 −0,16 324,61 −551 837 348 623 025
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 490 1 075 675 −0,14 323,42 −481 896 347 894 808
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −3 874 1 077 165 −0,36 322,34 −1 248 745 347 213 366
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −8 021 1 081 039 −0,74 321,48 −2 578 591 347 532 418
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −17 274 1 089 060 −1,56 320,48 −5 535 972 349 021 949
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −30 858 1 106 334 −2,71 319,44 −9 857 280 353 407 333
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −15 816 1 137 192 −1,37 318,52 −5 037 712 362 218 396
2014-02-13 2014-02-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −4 322 1 153 008 −0,37 317,82 −1 373 618 366 449 003
2014-02-13 2014-02-11 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 5 720 5 720
2014-02-13 2014-02-11 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −189 463 0 −100,00
2014-02-13 2014-02-11 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −94 756 1 157 330 −7,57 314,31 −29 782 758 363 760 392
2014-02-13 2014-02-11 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −5 720 1 252 086 −0,45 314,31 −1 797 853 393 543 151
2014-02-13 2014-02-11 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 189 463 1 257 806 17,73 9,49 1 798 004 11 936 579
2013-12-20 2013-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 705 0 −100,00
2013-12-20 2013-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 705 1 068 343 0,44 21,25 99 981 22 702 289
2013-12-17 2013-12-16 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −42 974 1 063 638 −3,88 272,73 −11 720 299 290 085 992
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 203 204 203 204
2013-12-17 2013-12-13 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 150 000 246 736 155,06
2013-12-13 2013-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −9 599 0 −100,00
2013-12-13 2013-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −228 1 106 612 −0,02 273,06 −62 258 302 171 473
2013-12-13 2013-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −9 154 1 106 840 −0,82 273,06 −2 499 591 302 233 730
2013-12-13 2013-12-12 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 9 599 1 115 994 0,87 260,44 2 499 964 290 649 477
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −400 1 106 395 −0,04 264,21 −105 684 292 320 623
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −38 267 1 106 795 −3,34 263,22 −10 072 640 291 330 580
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −47 876 1 145 062 −4,01 262,43 −12 564 099 300 498 621
2013-05-08 2013-05-07 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale −13 457 1 192 938 −1,12 261,66 −3 521 159 312 144 157
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 9 599 9 599
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −192 308 0 −100,00
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −93 644 1 206 395 −7,20 260,44 −24 388 643 314 193 514
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −9 599 1 300 039 −0,73 260,44 −2 499 964 338 582 157
2013-05-08 2013-05-06 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 192 308 1 309 638 17,21 13,00 2 500 004 17 025 294
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 562 0 −100,00
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −4 921 0 −100,00
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −5 952 0 −100,00
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −7 692 0 −100,00
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −17 182 0 −100,00
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Incentive Stock Option (right to buy) 		M - Exercise −10 537 0 −100,00
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 7 692 1 117 330 0,69 13,00 99 996 14 525 290
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 10 537 1 109 638 0,96 9,49 99 996 10 530 465
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 17 182 1 099 101 1,59 11,64 199 998 12 793 536
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 921 1 081 919 0,46 20,32 99 995 21 984 594
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 4 562 1 076 998 0,43 21,92 99 999 23 607 796
2012-12-21 2012-12-19 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 5 952 1 072 436 0,56 16,80 99 994 18 016 925
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −10 103 0 −100,00
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise X −266 10 103 −2,57
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −230 350 1 066 484 −17,76 179,13 −41 262 596 191 039 279
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −1 814 1 296 834 −0,14 179,13 −324 942 232 301 874
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −6 163 1 298 648 −0,47 179,13 −1 103 978 232 626 816
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 10 103 1 304 811 0,78 109,29 1 104 157 142 602 794
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −47 1 294 708 0,00 179,13 −8 419 231 921 044
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −161 1 294 755 −0,01 179,13 −28 840 231 929 463
2012-12-18 2012-12-17 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise X 266 1 294 916 0,02 109,29 29 071 141 521 370
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 239 063 239 063
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 150 000 245 295 157,41
2012-12-18 2012-12-14 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes X −38 391 1 294 650 −2,88 179,13 −6 876 980 231 910 654
2012-06-29 2012-06-27 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		A - Award 500 000 1 333 041 60,02
2012-05-02 2012-05-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −12 945 833 041 −1,53 135,29 −1 751 329 112 702 117
2012-05-02 2012-05-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −20 120 845 986 −2,32 134,54 −2 706 945 113 818 956
2012-05-02 2012-05-01 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −100 866 106 −0,01 133,95 −13 395 116 014 899
2012-03-27 2012-03-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −1 010 866 206 −0,12 121,09 −122 301 104 888 885
2012-03-27 2012-03-26 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −32 140 867 216 −3,57 120,21 −3 863 549 104 248 035
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 266 10 369 2,63
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		A - Award 10 103 10 103
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −3 430 0 −100,00
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) 		M - Exercise −129 902 3 430 −97,43
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −1 457 899 356 −0,16 109,29 −159 236 98 290 617
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −266 900 813 −0,03 109,29 −29 071 98 449 853
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 3 430 901 079 0,38 8,50 29 155 7 659 172
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −55 191 897 649 −5,79 109,29 −6 031 824 98 104 059
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		F - Taxes −10 103 952 840 −1,05 109,29 −1 104 157 104 135 884
2012-02-16 2012-02-15 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		M - Exercise 129 902 962 943 15,59 8,50 1 104 167 8 185 016
2012-01-06 2012-01-05 4 REGN REGENERON PHARMACEUTICALS INC
Common Stock 		S - Sale X −27 713 833 041 −3,22 58,00 −1 607 354 48 316 378
2010-12-21 2010-12-14 4/A REGN REGENERON PHARMACEUTICALS INC
Common Stock 		A - Award 250 000 870 375 40,30
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)